On 31 July 2019, Amgen Inc. (NASDAQ:AMGN) changed +5.74% to recent value of $186.58. The stock transacted 6,449,110 shares during most recent day however it has an average volume of 2,818,226 shares. It spotted trading -10.15% off 52-week high price. On the other end, the stock has been noted 6.58% away from the low price over the last 52-weeks. The company has 609.94M shares outstanding and market value of 113.8B.
Amgen (AMGN) recently reported financial results for the second quarter of 2k19. Key results include:
Cash Flow and Balance Sheet
2k19 Guidance
For the full year 2k19, the Company now expects:
Quick ratio for most recent quarter was 2.50 while current ratio for time period was 2.80. In most recent quarter, LT Debt/Equity ratio was listed at 2.71 and Total Debt/Equity ratio was noted at 3.05.
Amgen (AMGN) recently reported financial results for the second quarter of 2k19. Key results include:
- Total revenues reduced 3% to $5.9Bin comparison to the second quarter of 2k18 reflecting increasing competition Because of patent expirations.
- GAAP earnings per share (EPS) raised 3% to $3.57benefited by lower weighted-average shares outstanding.
- Non-GAAP EPS raised 4% to $3.97benefited by lower weighted-average shares outstanding.
- The Company generated $1.3Bof free cash flow in the second quarter versus $1.9B in the second quarter of 2k18 driven primarily by an advanced tax deposit payment.
- 2k19 total revenues guidance revised to $22.4-$22.9B; EPS guidance to $12.10-$12.71on a GAAP basis and $13.75-$14.30 on a non-GAAP basis.
Cash Flow and Balance Sheet
- The Company generated $1.3Bof free cash flow in the second quarter of 2k19 versus $1.9B in the second quarter of 2k18 driven primarily by an advanced tax deposit payment.
- The Company's second quarter 2k19 dividend of $1.45per share was reported on March 7, 2k19, and was paid on June 7, 2k19, to all stockholders of record as of May 17, 2k19, representing a 10% raise from 2k18.
- During the second quarter, the Company repurchased 13.1M shares of ordinary stock at a total cost of $2.3B. At the end of the second quarter, the Company had $4.7Bremaining under its stock repurchase authorization.
2k19 Guidance
For the full year 2k19, the Company now expects:
- Total revenues in the range of $22.4B to $22.9B.
- On a GAAP basis, EPS in the range of $12.10 to $12.71 and a tax rate in the range of 13% to 14%.
- On a non-GAAP basis, EPS in the range of $13.75 to $14.30 and a tax rate in the range of 14% to 15%.
- Capital expenditures to be about $700M.
Quick ratio for most recent quarter was 2.50 while current ratio for time period was 2.80. In most recent quarter, LT Debt/Equity ratio was listed at 2.71 and Total Debt/Equity ratio was noted at 3.05.
)
